Alkem Laboratories Ltd. (ALKEM) Share Price Rises 3.3% Today
- July 30, 2026
- Posted by: Harsh Piplani
- Category: News
Alkem Laboratories Ltd. Share Price rises 3.3% today, reaching Rs 5,860.95 with a market cap of Rs 67,559.01 crore.
Alkem Laboratories Ltd. Share Price has seen a notable increase today, rising by 3.3% to reach Rs 5,860.95. This movement positions the company within the Large Cap category, boasting a market capitalisation of Rs 67,559.01 crore. The stock opened at Rs 5,685 and reached a high of Rs 5,864, reflecting investor interest and market activity.
The share price gain of Alkem Laboratories Ltd. is noteworthy, given the absence of a specific catalyst in the supplied data. However, the increase in price and volume suggests heightened investor attention. With a total volume of 159,782 shares traded across BSE and NSE, the turnover reached Rs 5.89 crore, indicating active participation in today’s market.
Alkem Laboratories Ltd. (ALKEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,860.95 |
| Previous Close | Rs 5,673.5 |
| Today's Change | +Rs 187.45 (+3.3%) |
| Day Open | Rs 5,685 |
| Day High | Rs 5,864 |
| Day Low | Rs 5,680.2 |
| Current Volume (BSE) | 10,052 |
| BSE Traded Volume | 10,052 |
| NSE Traded Volume | 1,49,730 |
| Combined NSE + BSE Volume | 1,59,782 |
| Turnover | Rs 5.89 crore |
| Market Capitalisation | Rs 67,559.01 crore |
| Market Cap Category | Large Cap |
Alkem Laboratories Ltd. (ALKEM) traded at Rs 5,860.95. versus the previous close of Rs 5,673.5, a rise of 3.3%. The stock opened at Rs 5,685, reached Rs 5,864, touched Rs 5,680.2. Reported volume was 10,052.
Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 67,559.01 crore |
The sector snapshot reveals that the Healthcare sector comprises 198 companies, with Alkem Laboratories Ltd. being one of the prominent players. The sector’s ROE median is 10.74%, and the ROCE median is 13.24%, providing a benchmark for evaluating Alkem’s financial performance. Despite the absence of specific financial ratios for Alkem Laboratories Ltd., the sector data offers a comparative framework for analysis.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 26.56x |
| Benchmark Average P/E | 87.07x |
| Benchmark P/E Range | 3.47x to 3,385.56x |
| Benchmark Median P/B | 1.91x |
| Benchmark Median ROE | 10.74% |
| Benchmark Median ROCE | 13.24% |
| Company Market Capitalisation | Rs 67,559.01 crore |
| Benchmark Median Market Cap | Rs 138.42 crore |
Alkem Laboratories Ltd. (ALKEM) is classified under sector: Healthcare.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
The Healthcare sector, where Alkem Laboratories Ltd. operates, consists of 198 companies. The sector’s P/E median is 26.56, with an average of 87.07, indicating a wide range of valuations. Alkem Laboratories Ltd.’s market capitalisation of Rs 67,559.01 crore places it well above the sector’s median of Rs 138.42 crore, highlighting its significant market presence.
The sector’s ROE median is 10.74%, and the ROCE median is 13.24%, with Alkem Laboratories Ltd. likely positioned favourably within these benchmarks. The sector’s performance is diverse, with companies like Kwality Pharmaceuticals Ltd. and Hikal Ltd. showing varying financial metrics. Alkem Laboratories Ltd.’s position in the sector underscores its importance as a key player in the Healthcare industry.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,856.59 | 30.28 | 0.44 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,686.76 | 40.11 | 8.17 | 28.21 | 26.35 |
| Hikal Ltd. | HIKAL | 2,676.24 | 0 | 2.27 | 15.22 | 16.15 |
| Panacea Biotec Ltd. | PANACEABIO | 2,540.37 | 0 | 3.11 | 0 | 5.36 |
| Solara Active Pharma Sciences Ltd. | SOLARA | 2,446.19 | 0 | 1.91 | 17.23 | 15.34 |
Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 67,559.01 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Alkem Laboratories Ltd. competes with several peers in the Healthcare sector. Notable peers include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Hikal Ltd. These companies exhibit diverse financial metrics, with varying P/E, P/B, ROE, and ROCE values.
Alkem Laboratories Ltd.’s market capitalisation of Rs 67,559.01 crore is significantly higher than its peers, such as Kwality Pharmaceuticals Ltd. with a market cap of Rs 2,686.76 crore. This comparison highlights Alkem’s strong market position and its competitive edge in the sector.
Why Investors Are Watching Alkem Laboratories Ltd.
Investors are closely monitoring Alkem Laboratories Ltd. due to its recent price rise and strong market position.
- Price Action: Share price rose by 3.3% today, reaching Rs 5,860.95.
- Market Position: Large Cap category with a market cap of Rs 67,559.01 crore.
- Sector Context: Operates in the Healthcare sector, with favourable benchmarks.
- Peer Comparison: Strong market cap compared to peers.
Investors should continue to observe Alkem Laboratories Ltd.’s market performance and sector developments to make informed decisions.
About Alkem Laboratories Ltd.
Alkem Laboratories Ltd. is a prominent player in the Healthcare sector, specialising in pharmaceuticals and drugs. The company operates across various segments, focusing on the development, manufacture, and marketing of pharmaceutical products. Alkem Laboratories Ltd. has established a strong market presence, supported by its extensive product portfolio and commitment to quality.
The company’s operations are aligned with industry standards, ensuring compliance and excellence in its offerings. Alkem Laboratories Ltd. continues to innovate and expand its reach, contributing to its reputation as a leading pharmaceutical company in India.
Track Alkem Laboratories Ltd. Share Price on Univest
Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Stay updated with Alkem Laboratories Ltd. Share Price on Univest. Track live share prices, technical indicators, fundamental ratios, and market insights. Univest provides comprehensive data to help investors make informed decisions about Alkem Laboratories Ltd.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Alkem Laboratories Ltd.?
Ans. The current share price of Alkem Laboratories Ltd. is Rs 5,860.95, reflecting a 3.3% increase from the previous close of Rs 5,673.5. The stock moved 3.3% during the session. The intraday range extended from Rs 5,680.2 to Rs 5,864.
How much did Alkem Laboratories Ltd. share price rise today?
Ans. Alkem Laboratories Ltd. share price rose by 3.3% today, marking a significant gain in the Large Cap category. The stock moved 3.3% during the session. The intraday range extended from Rs 5,680.2 to Rs 5,864.
How does Alkem Laboratories Ltd. compare to its peers?
Ans. Alkem Laboratories Ltd. has a significantly higher market capitalisation compared to peers like Kwality Pharmaceuticals Ltd. and Hikal Ltd. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.
What is the P/E median for the Healthcare sector?
Ans. The P/E median for the Healthcare sector is 26.56, providing a benchmark for evaluating company valuations. The relevant peer median P/E is 26.56x. The peer average P/E is 87.07x. The stock belongs to the Healthcare sector.
What is the ROE median for the Healthcare sector?
Ans. The ROE median for the Healthcare sector is 10.74%, offering a benchmark for assessing financial performance. The relevant peer median ROE is 10.74%. The relevant peer median ROCE is 13.24%.
What is the ROCE median for the Healthcare sector?
Ans. The ROCE median for the Healthcare sector is 13.24%, serving as a benchmark for evaluating capital efficiency. The relevant peer median ROE is 10.74%. The relevant peer median ROCE is 13.24%.
